These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7179174)

  • 1. [Drug treatment of cerebral disorders in senility].
    Schelling JL
    Ther Umsch; 1982 Nov; 39(11):887-90. PubMed ID: 7179174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dementia-related diseases. Propentofyllin--a neuroprotective glia cell modulator].
    Nervenarzt; 1998 Feb; 69(2 Suppl Propentofy):1-4. PubMed ID: 9532231
    [No Abstract]   [Full Text] [Related]  

  • 3. Stimulants in senility: a neglected therapeutic option?
    Loew DM
    Pharmacopsychiatry; 1984 Nov; 17(6):177. PubMed ID: 6514779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
    Girard PE; Boucher M
    Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the treatment of cerebral nutrition disorders. A double blind study].
    Kirchberger F; Kehl R; Gutmann W
    Med Welt; 1969 Jul; 27():1542-6. PubMed ID: 4895204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of degenerative dementia disorders--who should be treated?].
    Hasselbalch SG; Kampmann JP
    Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
    Whitehouse PJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():2-5. PubMed ID: 9305506
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 9. Physostigmine in the treatment of memory disorders: a case report.
    Denber HC
    Psychiatr J Univ Ott; 1982 Mar; 7(1):8-12. PubMed ID: 7051074
    [No Abstract]   [Full Text] [Related]  

  • 10. Ergots in the treatment of mental disorders of old age.
    Gaitz CM; Hartford JT
    Adv Biochem Psychopharmacol; 1980; 23():349-56. PubMed ID: 7395621
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurochemical approaches to the treatment of senile dementia.
    Growdon JH; Corkin S
    Proc Annu Meet Am Psychopathol Assoc; 1980; 69():281-96. PubMed ID: 7413654
    [No Abstract]   [Full Text] [Related]  

  • 12. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues in the economic evaluation of treatment for dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Winblad B; Hill S; Beermann B; Post SG; Wimo A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():39-45. PubMed ID: 9305515
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of behavioral abnormalities in patients with dementia].
    Wolf H; Gertz HJ
    MMW Fortschr Med; 2004 Jun; 146(24):43-5. PubMed ID: 15366492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choline bitartrate treatment of Alzheimer-type dementias.
    Fovall P; Dysken MW; Lazarus LW; Davis JM; Kahn RL; Jope R; Finkel S; Rattan P
    Commun Psychopharmacol; 1980; 4(2):141-5. PubMed ID: 7428335
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current antidementive therapy].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract]   [Full Text] [Related]  

  • 18. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 19. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients.
    Summers WK; Viesselman JO; Marsh GM; Candelora K
    Biol Psychiatry; 1981 Feb; 16(2):145-53. PubMed ID: 7225483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.